Quantitative assay for testing susceptibility of HIV isolates to zidovudine and sCD4 (178)-PE40 (Q41610707)

5 October 2017

title

Quantitative assay for testing susceptibility of HIV isolates to zidovudine and sCD4 (178)-PE40 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425730

25 September 2022

1 reference

J. Verhoef

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425730

25 September 2022

G. Gekker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425730

25 September 2022

A. Erice

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425730

25 September 2022

P. K. Peterson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425730

25 September 2022

H. H. Balfour

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1425730

25 September 2022

language of work or name

1 reference

1 August 1992

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

5 October 2017

published in

1 reference

5 October 2017

volume

11

1 reference

5 October 2017

issue

8

1 reference

5 October 2017

page(s)

715-721

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01989976

5 October 2017

exact match

0 references

cites work

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1007%2FBF01989976

Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01989976

Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01989976

Effects of thymidine and uridine on the phosphorylation of 3'-azido-3'-deoxythymidine (zidovudine) in human mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01989976

AZT demonstrates anti-HIV-1 activity in persistently infected cell lines: implications for combination chemotherapy and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01989976

Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow

21 January 2018

1 reference

12 December 2020

Nature, time course and dose dependence of zidovudine-related side effects: results from the Multicenter Canadian Azidothymidine Trial

1 reference

12 December 2020

Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines

1 reference

12 December 2020

Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides

1 reference

12 December 2020

AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells

1 reference

12 December 2020

Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus

1 reference

12 December 2020

Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals

1 reference

12 December 2020

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

12 December 2020

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

1 reference

12 December 2020

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein

1 reference

12 December 2020

CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses

1 reference

12 December 2020

Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures

1 reference

12 December 2020

Rapid and sensitive viral culture method for human immunodeficiency virus type 1.

1 reference

12 December 2020

Selective inhibition of human immunodeficiency virus (HIV) by 3'-azido-2', 3'-dideoxyguanosine in vitro

1 reference

12 December 2020

Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01989976

1 reference

Dimensions Publication ID

5 October 2017

1040583569

0 references

1 reference